James Cummings
2021
In 2021, James Cummings earned a total compensation of $2.4M as Chief Medical Officer at Biota Pharmaceuticals.
Compensation breakdown
Non-Equity Incentive Plan | $36,092 |
---|---|
Option Awards | $2,228,040 |
Salary | $112,154 |
Other | $3,707 |
Total | $2,379,993 |
Cummings received $2.2M in option awards, accounting for 94% of the total pay in 2021.
Cummings also received $36.1K in non-equity incentive plan, $112.2K in salary and $3.7K in other compensation.
Rankings
In 2021, James Cummings' compensation ranked 5,350th out of 12,415 executives tracked by ExecPay. In other words, Cummings earned more than 56.9% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 5,350 out of 12,415 | 57th |
Division Manufacturing | 2,251 out of 5,508 | 59th |
Major group Chemicals And Allied Products | 981 out of 2,378 | 59th |
Industry group Drugs | 873 out of 2,099 | 58th |
Industry Biological Products, Except Diagnostic Substances | 215 out of 449 | 52nd |
Source: SEC filing on April 28, 2023.
Cummings' colleagues
We found two more compensation records of executives who worked with James Cummings at Biota Pharmaceuticals in 2021.